AIFA – Nota informativa importante sugli inibitori SGLT2
21/03/2016 http://www.agenziafarmaco.gov.it/it/content/aifa-nota-informativa-importante-sugli-inibitori-sglt2
Leggi
Breaking news
NICE GUIDANCE – Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar)
Dicembre 2015
NICE GUIDANCE – Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar)
Leggi
FDA – Interference between Computed Tomography (CT) and Electronic Medical Devices: Notification – Current Understanding of Potential Risk
01/04/2016 http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm493739.htm
Leggi
FDA Drug Safety Communication: FDA eliminates the Risk Evaluation and Mitigation Strategy (REMS) for rosiglitazone-containing diabetes medicines
16712/2015
FDA Drug Safety Communication: FDA eliminates the Risk Evaluation and Mitigation Strategy (REMS) for rosiglitazone-containing diabetes medicines
Leggi
FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes
16/12/2015
FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes
Leggi
FDA – Diabetes medications containing Saxagliptin and Alogliptin: Drug safety communication – Risk of heart failure
05/04/2016
FDA – Diabetes medications containing Saxagliptin and Alogliptin: Drug safety communication – Risk of heart failure
Leggi
Standards of Medical Care in Diabetes – 2016
Diabetes Care 2016;39:S4-S5 http://care.diabetesjournals.org/content/39/Supplement_1
Leggi
FDA approves Integra Omnigraft Dermal Regeneration Matrix to treat diabetic foot ulcers.
January 7, 2016 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm480564.htm
Leggi
FDA – Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function
08/04/2016 http://www.fda.gov/Drugs/DrugSafety/ucm493244.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
Leggi
EMA – Reviews diabetes medicine canagliflozin – Review follows data on toe amputations in ongoing study
15/04/2016
EMA – Reviews diabetes medicine canagliflozin – Review follows data on toe amputations in ongoing study
Leggi